KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Amortization - Intangibles: 2015-2024

Historic Amortization - Intangibles for Sarepta Therapeutics (SRPT) over the last 10 years, with Dec 2024 value amounting to $2.4 million.

  • Sarepta Therapeutics' Amortization - Intangibles changed negligibly% to $601,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.4 million, marking a year-over-year increase of 0.04%. This contributed to the annual value of $2.4 million for FY2024, which is 54.27% up from last year.
  • As of FY2024, Sarepta Therapeutics' Amortization - Intangibles stood at $2.4 million, which was up 54.27% from $1.6 million recorded in FY2023.
  • Over the past 5 years, Sarepta Therapeutics' Amortization - Intangibles peaked at $2.4 million during FY2024, and registered a low of $700,000 during FY2020.
  • Moreover, its 3-year median value for Amortization - Intangibles was $1.6 million (2023), whereas its average is $1.6 million.
  • Per our database at Business Quant, Sarepta Therapeutics' Amortization - Intangibles dropped by 17.55% in 2020 and then surged by 118.35% in 2023.
  • Over the past 5 years, Sarepta Therapeutics' Amortization - Intangibles (Yearly) stood at $700,000 in 2020, then climbed by 0.86% to $706,000 in 2021, then climbed by 1.13% to $714,000 in 2022, then soared by 118.35% to $1.6 million in 2023, then surged by 54.27% to $2.4 million in 2024.